Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-20-000182

Director sold 5,000 shares at an average $266.42 ($1,332,117)

  • Director acquired 5,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
BAUMGARTNER ROBERT V Director 2020-05-21 Option exercise +5,000 $70.35 $351,750 14,221 D: show line 1 in the form
BAUMGARTNER ROBERT V Director 2020-05-21 Sale −1,300 $265.35 $344,960 12,921 D: show line 2 in the form
BAUMGARTNER ROBERT V Director 2020-05-21 Sale −1,601 $266.07 $425,979 11,320 D: show line 3 in the form
BAUMGARTNER ROBERT V Director 2020-05-21 Sale −1,974 $267.32 $527,685 9,346 D: show line 4 in the form
BAUMGARTNER ROBERT V Director 2020-05-21 Sale −125 $267.94 $33,493 9,221 D: show line 5 in the form
Open-market sales · 5,000 sh · avg $266.42 · $1,332,117

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
BAUMGARTNER ROBERT V Director 2020-05-21 Option exercise · Stock Options (right to Buy) −5,000 0 D: show line 6 in the form
Loading xslF345X03/edgar.xml…